Last reviewed · How we verify
Placebo for Vitamin C and Vitamin E
This drug is a placebo for Vitamin C and Vitamin E, meaning it has no active therapeutic effect.
This drug is a placebo for Vitamin C and Vitamin E, meaning it has no active therapeutic effect. Used for Prevention of Vitamin C and Vitamin E deficiency.
At a glance
| Generic name | Placebo for Vitamin C and Vitamin E |
|---|---|
| Sponsor | The George Washington University Biostatistics Center |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological pathways or molecular targets. It is used as a control in clinical trials to compare the effects of active treatments.
Approved indications
- Prevention of Vitamin C and Vitamin E deficiency
Common side effects
Key clinical trials
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (PHASE2)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Developing a Nutritional Supplement to Increase Collagen Synthesis in People (NA)
- Alii Supplement Study (PHASE2)
- Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT) (PHASE2)
- Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects (NA)
- This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control (PHASE4)
- Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: